![MAPS' Phase 3 Trial of MDMA-Assisted Therapy for PTSD Achieves Successful Results for Patients with Severe, Chronic PTSD - Multidisciplinary Association for Psychedelic Studies - MAPS MAPS' Phase 3 Trial of MDMA-Assisted Therapy for PTSD Achieves Successful Results for Patients with Severe, Chronic PTSD - Multidisciplinary Association for Psychedelic Studies - MAPS](https://i0.wp.com/maps.org/wp-content/uploads/2021/05/MAPP1-Infographic4.png?ssl=1)
MAPS' Phase 3 Trial of MDMA-Assisted Therapy for PTSD Achieves Successful Results for Patients with Severe, Chronic PTSD - Multidisciplinary Association for Psychedelic Studies - MAPS
![MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo- controlled phase 3 study | Nature Medicine MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo- controlled phase 3 study | Nature Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-021-01336-3/MediaObjects/41591_2021_1336_Fig3_HTML.png)
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo- controlled phase 3 study | Nature Medicine
![3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial - The Lancet Psychiatry 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial - The Lancet Psychiatry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2119334735/2092340887/gr1.gif)